Efficacy of tranexamic acid for reducing postpartum blood loss after vaginal delivery : a randomized control trial, double blind.
Phase 4
Recruiting
- Conditions
- Pregnancy
- Registration Number
- TCTR20161104004
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Age >18 years
Normal delivery
Gestational age > 36 week
Singleton
Exclusion Criteria
-History of venous thrombosis (deep vein thrombosis and or pulmonary embolism)
or arterial thrombosis (angina pectoris, myocardial infarction, stroke)
-History of epilepsy or seizure
-Underlying disease cardiovascular,renal,liver disorders,Autoimmune disease
-Abnormal placenta : Placenta previa, Abnormally invasive placenta (placenta accreta/increta/percreta), Abruptio placenta 

-Preeclampsia with or without severe feature, Eclampsia,HELLP syndrome 

-Multiple pregnancy
-DFIU
-Vaccuum extraction, Forcep extraction 

-History of maternal use LMWH or anti platelet agents 1 week before delivery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postpartum blood loss 2 hour after postpartum randomized controlled trial,Postpartum blood loss 2 hour after postpartum randomized controlled trial
- Secondary Outcome Measures
Name Time Method Incidence of Postpartum hemorrhage 2 hr after Postpartum randomized controlled trial,Postpartum hematocrit change 2 hr after Postpartum randomized controlled trial,Use other uterotonic agent 2 hr after Postpartum randomized controlled trial,Thromboembolic even and side effect 2 hr after Postpartum randomized controlled trial